Figure 1.
The 7-year CIR and TRM (competing risk) according to the presence of a PT-LU shared HLA mismatch against the WU. (A) CIR and TRM according to the presence of a PT-LU HLA-A shared mismatch against the WU. With no PT-LU HLA-A shared mismatch (n = 315) the CIR was 28% (95% CI, 23-34) vs 16% (95% CI, 7-25) with a PT-LU HLA-A shared mismatch (n = 68). With no PT-LU HLA-A shared mismatch, the TRM was 25% (95% CI, 20-30) vs 26% (95% CI, 15-37) with a PT-LU HLA-A shared mismatch. (B) CIR and TRM according to the presence of a PT-LU HLA-B shared mismatch against the WU. With no PT-LU HLA-B shared mismatch (n = 325) the CIR was 28% (95% CI, 23-33) vs 15% (95% CI, 5-24) with a PT-LU HLA-B shared mismatch (n = 58). With no PT-LU HLA-A shared mismatch the TRM was 25% (95% CI, 20-30) vs 30% (95% CI, 17-42) with a PT-LU HLA-B shared mismatch. (C) CIR and TRM according to the presence of a PT-LU shared HLA-C mismatch against the WU. With no PT-LU HLA-C shared mismatch (n = 306) the CIR was 27% (95% CI, 22-32) vs 22% (95% CI, 12-31) with a PT-LU HLA-C shared mismatch (n = 77). With no PT-LU HLA-C shared mismatch the TRM was 26% (95% CI, 21-31) vs 24% (95% CI, 14-34) with a PT-LU HLA-C shared mismatch. (D) CIR and TRM according to the presence of a PT-LU shared HLA-DRB1 mismatch against the WU. With no PT-LU HLA-DRB1 shared mismatch (n = 335) the CIR was 26% (95% CI, 21-31) vs 28% (95% CI, 13-42) with a PT-LU HLA-DRB1 shared mismatch (n = 47). With no PT-LU HLA-DRB1 shared mismatch the TRM was 24% (95% CI, 20-29) vs 34% (95% CI, 20-48) with a PT-LU HLA-DRB1 shared mismatch.

The 7-year CIR and TRM (competing risk) according to the presence of a PT-LU shared HLA mismatch against the WU. (A) CIR and TRM according to the presence of a PT-LU HLA-A shared mismatch against the WU. With no PT-LU HLA-A shared mismatch (n = 315) the CIR was 28% (95% CI, 23-34) vs 16% (95% CI, 7-25) with a PT-LU HLA-A shared mismatch (n = 68). With no PT-LU HLA-A shared mismatch, the TRM was 25% (95% CI, 20-30) vs 26% (95% CI, 15-37) with a PT-LU HLA-A shared mismatch. (B) CIR and TRM according to the presence of a PT-LU HLA-B shared mismatch against the WU. With no PT-LU HLA-B shared mismatch (n = 325) the CIR was 28% (95% CI, 23-33) vs 15% (95% CI, 5-24) with a PT-LU HLA-B shared mismatch (n = 58). With no PT-LU HLA-A shared mismatch the TRM was 25% (95% CI, 20-30) vs 30% (95% CI, 17-42) with a PT-LU HLA-B shared mismatch. (C) CIR and TRM according to the presence of a PT-LU shared HLA-C mismatch against the WU. With no PT-LU HLA-C shared mismatch (n = 306) the CIR was 27% (95% CI, 22-32) vs 22% (95% CI, 12-31) with a PT-LU HLA-C shared mismatch (n = 77). With no PT-LU HLA-C shared mismatch the TRM was 26% (95% CI, 21-31) vs 24% (95% CI, 14-34) with a PT-LU HLA-C shared mismatch. (D) CIR and TRM according to the presence of a PT-LU shared HLA-DRB1 mismatch against the WU. With no PT-LU HLA-DRB1 shared mismatch (n = 335) the CIR was 26% (95% CI, 21-31) vs 28% (95% CI, 13-42) with a PT-LU HLA-DRB1 shared mismatch (n = 47). With no PT-LU HLA-DRB1 shared mismatch the TRM was 24% (95% CI, 20-29) vs 34% (95% CI, 20-48) with a PT-LU HLA-DRB1 shared mismatch.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal